Biotechnology Innovation Organization

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the finalization of the GLOBE model. “Biotechnology is one of America's greatest strengths, delivering medical miracles to patients, driving economic growth, and advancing our national security.

Submitting a proposal is free. If your proposal is accepted, you'll receive a complimentary General Access registration to BIO 2027, including hundreds of sessions, featured programming, networking receptions, and more. The submission deadline is October 15, 2026. Individuals whose proposals have been selected will be notified mid-January 2027. Need help getting started? Preview 2027 Submission Tips and FAQs. A complete guide is available once you log in to the BIO Program Portal.

WASHINGTON, DC (August 31, 2026) – Today, the Biotechnology Innovation Organization (BIO) awarded Nevada Governor Joe Lombardo with its 2026 Governor of the Year Award, recognizing his leadership in growing the life sciences in Nevada and commitment to biomedical innovation.

CEO Savanna Bio Robert Spitale, Ph.D., is the co-founder and CEO of Savanna Biotherapeutics, where he leads the development of the world's first iPSC-derived microglia cell therapy platform for neurodegenerative disease.

Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the commitment letter: “For more than 30 years, PDUFA has helped deliver hundreds of new medicines to American patients.

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act in the Senate: “Moving the PASTEUR Act of 2026 forward marks meaningful progress in tackling one of our most serious public health crises.

At BIO 2026, where science meets real-world impact, you can access more than 150 sessions across 18 focus areas with discussions from leading experts. Use the search, filter, and AI generate itinerary tools to plan out your calendar with your own “must see” sessions, or find sessions by job role (from the main navigation). Accelerate your career growth by adding a Professional Development Course to your BIO 2026 registration. Learn more.

SAN DIEGO (June 22, 2026) - The BIO International Convention (BIO 2026), the world’s largest and most comprehensive event for the biotechnology industry, begins today in San Diego. The convention brings together 20,000+ biotech and life sciences leaders from around the world. This year’s theme, “Driven by Purpose,” reflects the industry’s commitment to solve the impossible, push boundaries, and deliver better outcomes for patients, public health, and the world.

This session will explore how pharma/biotech companies achieve pipeline diversity through portfolio strategy, strategic collaborations, and scientific rigor. The conversation will examine the processes behind diversification, including how companies identify emerging opportunities, leverage external innovation, allocate resources across modalities and disease areas, and adapt to evolving market and scientific landscapes.